Phage display - A powerful technique for immunotherapy: 2. Vaccine delivery

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 12, 2012, Pages 1829-1835

  Bazan, Justyna ^a   Całkosiński, Ireneusz ^a   Gamian, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Abuse treatment; Allergen immunotherapy; Antibody libraries; Clinical applications; Contraceptive vaccines; Immune diagnostics; Phage display; Vaccine design

Indexed keywords

ALANINE AMINOTRANSFERASE; ALANINE AMINOTRANSFERASE 2; BACTERIAL VACCINE; CANCER VACCINE; COCAINE VACCINE; CONTRACEPTIVE VACCINE; DNA VACCINE; DRUG VEHICLE; DRUGS USED IN THE TREATMENT OF ADDICTION; EC26 2A4; FUNGUS VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN FRAGMENT; IMMUNOLOGICAL ADJUVANT; LEUCINELYSYLVALYLISOLEUCYLARGINYLLYSINE VACCINE; MEROZOITE SURFACE PROTEIN 1; METHAMPHETAMINE VACCINE; MSC 0029; MSC 0108; MSC 0636; PARASITE VACCINE; PROTEIN MSC 0029; PROTEIN MSC 0108; PROTEIN MSC 0636; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; STREPTOCOCCUS VACCINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ALLERGIC DISEASE; ANTIBODY AFFINITY; ANTIBODY LIBRARY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BRUGIAN FILARIASIS; CANCER THERAPY; CANDIDIASIS; CELLULAR IMMUNITY; COCAINE DEPENDENCE; CONTAGIOUS PLEUROPNEUMONIA; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; EXPRESSION VECTOR; HERPES SIMPLEX; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOCONTRACEPTION; IMMUNOGENICITY; IMMUNOSTIMULATION; IMMUNOTHERAPY; INFECTION PREVENTION; LIGAND BINDING; MALARIA FALCIPARUM; MYCOPLASMA MYCOIDES; NONHUMAN; PHAGE DISPLAY; PROTEIN PROTEIN INTERACTION; REVIEW; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS INFECTION; VACCINE PRODUCTION;

ABUSE TREATMENT; ALLERGEN IMMUNOTHERAPY; ANTIBODY LIBRARIES; CLINICAL APPLICATIONS; CONTRACEPTIVE VACCINES; IMMUNE-DIAGNOSTICS; PHAGE DISPLAY; VACCINE DESIGN;

CELL SURFACE DISPLAY TECHNIQUES; CLINICAL LABORATORY TECHNIQUES; DRUG DISCOVERY; HUMANS; IMMUNOTHERAPY; VACCINES;

EID: 84872224887     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.21704     Document Type: Review

References (108)

1. Juillerat A, Gronemeyer T, Keppler A, Gendreizig S, Pick H, Vogel H, et al. Directed evolution of O6-alkylguanine-DNA alkyltransferase for efficient labeling of fusion proteins with small molecules in vivo. Chem Biol 2003; 10:313-7; PMID:12725859; http://dx.doi.org/10.1016/S1074-5521(03)00068-1.
2. Xia G, Chen L, Sera T, Fa M, Schultz PG, Romesberg FE. Directed evolution of novel polymerase activities: mutation of a DNA polymerase into an efficient RNA polymerase. Proc Natl Acad Sci USA 2002; 99:6597-602; PMID:12011423; http://dx.doi.org/10.1073/pnas.102577799.
3. Hekim C, Leinonen J, Närvänen A, Koistinen H, Zhu L, Koivunen E, et al. Novel peptide inhibitors of human kallikrein 2. J Biol Chem 2006; 281:12555-60; PMID:16527822; http://dx.doi.org/10.1074/jbc.M600014200.
4. Scholle MD, Kriplani U, Pabon A, Sishtla K, Glucksman MJ, Kay BK. Mapping protease substrates by using a biotinylated phage substrate library. Chembiochem 2006; 7:834-8; PMID:16628754; http://dx.doi.org/10.1002/cbic. 200500427.
5. Varadarajan N, Gam J, Olsen MJ, Georgiou G, Iverson BL. Engineering of protease variants exhibiting high catalytic activity and exquisite substrate selectivity. Proc Natl Acad Sci USA 2005; 102:6855-60; PMID:15867160; http://dx.doi.org/10.1073/pnas.0500063102.
6. Kay BK, Kasanov J, Yamabhai M. Screening phage-displayed combinatorial peptide libraries. Methods 2001; 24:240-6; PMID:11403573; http://dx.doi.org/10. 1006/meth.2001.1185.
7. Fischer N, Riechmann L, Winter G. A native-like artificial protein from antisense DNA. Protein Eng Des Sel 2004; 17:13-20; PMID:14985533; http://dx.doi.org/10.1093/protein/gzh002.
8. Chu R, Takei J, Knowlton JR, Andrykovitch M, Pei W, Kajava AV, et al. Redesign of a four-helix bundle protein by phage display coupled with proteolysis and structural characterization by NMR and X-ray crystallography. J Mol Biol 2002; 323:253-62; PMID:12381319; http://dx.doi.org/10.1016/S0022- 2836(02)00884-7.
9. Meyer T, Stratmann-Selke J, Meens J, Schirrmann T, Gerlach GF, Frank R, et al. Isolation of scFv fragments specific to OmpD of Salmonella Typhimurium. Vet Microbiol 2011; 147:162-9; PMID:20708859; http://dx.doi.org/10.1016/j. vetmic.2010.06.023.
10. rd, Ibrahim MS, Ikuta K, et al. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library. Biochem Biophys Res Commun 2010; 395:496-501; PMID:20382115; http://dx.doi.org/10.1016/ j.bbrc.2010.04.040.
11. Schütte M, Thullier P, Pelat T, Wezler X, Rosenstock P, Hinz D, et al. Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS ONE 2009; 4:e6625; PMID:19675673; http://dx.doi.org/10.1371/journal.pone. 0006625.
12. Chakravarthy B, Ménard M, Brown L, Atkinson T, Whitfield J. Identification of protein kinase C inhibitory activity associated with a polypeptide isolated from a phage display system with homology to PCM-1, the pericentriolar material-1 protein. Biochem Biophys Res Commun 2012; 424:147-51; PMID:22732405; http://dx.doi.org/10.1016/j.bbrc.2012.06.093.
13. Bugli F, Paroni Sterbini F, Graffeo R, Caridi F, Iantomasi R, Torelli R, et al. Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection. New Microbiol 2011; 34:281-6; PMID:21811748.
14. Filfil R, Paul-Roc B, Cantin C, Iqbal U, Tolkatchev D, Vinogradova A, et al. Molecular imaging of breast tumors using a near-infrared fluorescently labeled clusterin binding peptide. Int J Cancer 2012; 131:E681-92; PMID:22119929; http://dx.doi.org/10.1002/ijc.27368.
15. Nilvebrant J, Alm T, Hober S. Orthogonal protein purification facilitated by a small bispecific affinity tag. J Vis Exp 2012; In Press; PMID:22297419; http://dx.doi.org/10.3791/3370.
16. Miller SJ, Lee CM, Joshi BP, Gaustad A, Seibel EJ, Wang TD. Targeted detection of murine colonic dysplasia in vivo with flexible multispectral scanning fiber endoscopy. J Biomed Opt 2012; 17:021103; PMID:22463021; http://dx.doi.org/10.1117/1.JBO.17.2.021103.
17. Angenendt P, Wilde J, Kijanka G, Baars S, Cahill DJ, Kreutzberger J, et al. Seeing better through a MIST: evaluation of monoclonal recombinant antibody fragments on microarrays. Anal Chem 2004; 76:2916-21; PMID:15144205; http://dx.doi.org/10.1021/ac035357a.
18. Chang WJ, Kishikawa-Kiyama M, Shibata Y, Lee SY, Abiko Y. Inhibition of Porphyromonas gingivalis hemagglutinating activity by synthetic peptides derived from phage display selection using MAb against the recombinant outer membrane protein. Hybrid Hybridomics 2004; 23:352-6; PMID:15684661; http://dx.doi.org/10. 1089/hyb.2004.23.352.
19. Lillo AM, Ayriss JE, Shou Y, Graves SW, Bradbury AR, Pavlik P. Development of phage-based single chain Fv antibody reagents for detection of Yersinia pestis. PLoS ONE 2011; 6:e27756; PMID:22174746; http://dx.doi.org/10. 1371/journal.pone.0027756.
20. Pai S, Ellington AD, Levy M. Proximity ligation assays with peptide conjugate 'burrs' for the sensitive detection of spores. Nucleic Acids Res 2005; 33:e162; PMID:16237122; http://dx.doi.org/10.1093/nar/gni150.
21. Schlingemann J, Leijon M, Yacoub A, Schlingemann H, Zohari S, Matyi-Tóth A, et al. Novel means of viral antigen identification: improved detection of avian influenza viruses by proximity ligation. J Virol Methods 2010; 163:116-22; PMID:19751768; http://dx.doi.org/10.1016/j.jviromet. 2009.09.008.
22. Chen L, Wang Y, Cheng D, Dou S, Liu X, Liu G, et al. Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents. Nucl Med Commun 2011; 32:920-4; PMID:21876403; http://dx.doi.org/10. 1097/MNM.0b013e328348fc64.
23. Mashayekhi F, Chiu RY, Le AM, Chao FC, Wu BM, Kamei DT. Enhancing the lateral-flow immunoassay for viral detection using an aqueous two-phase micellar system. Anal Bioanal Chem 2010; 398:2955-61; PMID:20865404; http://dx.doi.org/10.1007/s00216-010-4213-7.
24. Guo YC, Zhou YF, Zhang XE, Zhang ZP, Qiao YM, Bi LJ, et al. Phage display mediated immuno-PCR. Nucleic Acids Res 2006; 34:e62; PMID:16682441; http://dx.doi.org/10.1093/nar/gkl260.
25. Ozers MS, Marks BD, Gowda K, Kupcho KR, Ervin KM, De Rosier T, et al. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Biochemistry 2007; 46:683-95; PMID:17223690; http://dx.doi.org/10.1021/bi061321b.
26. Ueberberg S, Meier JJ, Waengler C, Schechinger W, Dietrich JW, Tannapfel A, et al. Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo. Diabetes 2009; 58:2324-34; PMID:19592622; http://dx.doi.org/10.2337/db09-0658.
27. Gonzalez-Dosal R, Sørensen MD, Clark BF, Rattan SI, Kristensen P. Phage-displayed antibodies for the detection of glycated proteasome in aging cells. Ann N Y Acad Sci 2006; 1067:474-8; PMID:16804029; http://dx.doi.org/10. 1196/annals.1354.068.
28. Bastien N, Trudel M, Simard C. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus. Virology 1997; 234:118-22; PMID:9234952; http://dx.doi.org/10.1006/viro.1997.8632.
29. Kobayashi N, Oyama H, Nakano M, Kanda T, Banzono E, Kato Y, et al. "Cleavable" hapten-biotin conjugates: preparation and use for the generation of anti-steroid single-domain antibody fragments. Anal Biochem 2009; 387:257-66; PMID:19454256; http://dx.doi.org/10.1016/j.ab.2009.01.004.
30. Hashiguchi S, Yamaguchi Y, Takeuchi O, Akira S, Sugimura K. Immunological basis of M13 phage vaccine: Regulation under MyD88 and TLR9 signaling. Biochem Biophys Res Commun 2010; 402:19-22; PMID:20875795; http://dx.doi.org/10.1016/j. bbrc.2010.09.094.
31. Peachman KK, Li Q, Matyas GR, Shivachandra SB, Lovchik J, Lyons RC, et al. Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores. Clin Vaccine Immunol 2012; 19:11-6; PMID:22089245; http://dx.doi.org/10.1128/ CVI.05376-11.
32. Ledón T, Ferrán B, Pérez C, Suzarte E, Vichi J, Marrero K, et al. TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera. Microbes Infect 2012; In Press; PMID:22546527; http://dx.doi.org/10.1016/j.micinf.2012.04.004.
33. Ulivieri C, Citro A, Ivaldi F, Mascolo D, Ghittoni R, Fanigliulo D, et al. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides. Immunol Lett 2008; 119:62-70; PMID:18538862; http://dx.doi.org/10.1016/j.imlet.2008.04.004.
34. Bruttin A, Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 2005; 49:2874-8; PMID:15980363; http://dx.doi.org/10.1128/AAC.49.7.2874-2878. 2005.
35. Riemer AB, Hantusch B, Sponer B, Kraml G, Hafner C, Zielinski CC, et al. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells. Cancer Immunol Immunother 2005; 54:677-84; PMID:15565329; http://dx.doi.org/10.1007/s00262-004-0632-7.
36. Coomber DW, Ward RL. Isolation of human antibodies against the central DNA binding domain of p53 from an individual with colorectal cancer using antibody phage display. Clin Cancer Res 2001; 7:2802-8; PMID:11555596.
37. Wagner S, Hafner C, Allwardt D, Jasinska J, Ferrone S, Zielinski CC, et al. Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro. J Immunol 2005; 174:976-82; PMID:15634921.
38. Hardy B, Raiter A. A mimotope peptide-based anticancer vaccine selected by BAT monoclonal antibody. Vaccine 2005; 23:4283-91; PMID:15919139; http://dx.doi.org/10.1016/j.vaccine.2005.04.009.
39. Cuesta AM, Suárez E, Larsen M, Jensen KB, Sanz L, Compte M, et al. Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Immunology 2006; 117:502-6; PMID:16556264; http://dx.doi.org/10.1111/j.1365-2567.2006.02325.x.
40. Wang LF, Yu M. Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets 2004; 5:1-15; PMID:14738215; http://dx.doi.org/10.2174/1389450043490668.
41. Nencioni A, Grüenbach F, Patrone F, Brossart P. Anticancer vaccination strategies. Ann Oncol 2004; 15(Suppl 4):iv153-60; PMID:15477300; http://dx.doi.org/10.1093/annonc/mdh920.
42. Fang J, Wang G, Yang Q, Song J, Wang Y, Wang L. The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. Vaccine 2005; 23:4860-6; PMID:16029917; http://dx.doi.org/10.1016/ j.vaccine.2005.05.024.
43. Arnaiz B, Madrigal-Estebas L, Todryk S, James TC, Doherty DG, Bond U. A novel method to identify and characterise peptide mimotopes of heat shock protein 70-associated antigens. J Immune Based Ther Vaccines 2006; 4:2; PMID:16603084; http://dx.doi.org/10.1186/1476-8518-4-2.
44. van der Vaart JM, Pant N, Wolvers D, Bezemer S, Hermans PW, Bellamy K, et al. Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine 2006; 24:4130-7; PMID:16616802; http://dx.doi.org/10.1016/j.vaccine.2006.02.045.
45. Guo Z, Zhang H, Rao H, Jiang D, Cong X, Feng B, et al. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response. PLoS ONE 2012; 7:e38390; PMID:22701633; http://dx.doi.org/10.1371/journal.pone.0038390.
46. Iborra S, Izquierdo HM, Martínez-López M, Blanco-Menéndez N, Reis e Sousa C, Sancho D. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest 2012; 122:1628-43; PMID:22505455; http://dx.doi.org/10.1172/JCI60660.
47. Varela-Rohena A, Molloy PE, Dunn SM, Li Y, Suhoski MM, Carroll RG, et al. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med 2008; 14:1390-5; PMID:18997777; http://dx.doi.org/10.1038/nm. 1779.
48. Wan Y, Wu Y, Bian J, Wang XZ, Zhou W, Jia ZC, et al. Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine. Vaccine 2001; 19:2918-23; PMID:11282203; http://dx.doi.org/10.1016/S0264-410X(00)00561-2.
49. Santini C, Brennan D, Mennuni C, Hoess RH, Nicosia A, Cortese R, et al. Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda. J Mol Biol 1998; 282:125-35; PMID:9733645; http://dx.doi.org/10.1006/jmbi.1998.1986.
50. Hashemi H, Bamdad T, Jamali A, Pouyanfard S, Mohammadi MG. Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine. J Virol Methods 2010; 163:440-4; PMID:19903497; http://dx.doi.org/10. 1016/j.jviromet.2009.11.008.
51. Tumban E, Peabody J, Peabody DS, Chackerian B. A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2. PLoS ONE 2011; 6:e23310; PMID:21858066; http://dx.doi.org/10.1371/journal.pone.0023310.
52. Caldeira JdoC, Medford A, Kines RC, Lino CA, Schiller JT, Chackerian B, et al. Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7. Vaccine 2010; 28:4384-93; PMID:20434554; http://dx.doi.org/10.1016/j.vaccine.2010.04.049.
53. Slupetzky K, Gambhira R, Culp TD, Shafti-Keramat S, Schellenbacher C, Christensen ND, et al. A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11. Vaccine 2007; 25:2001-10; PMID:17239496; http://dx.doi.org/10.1016/j.vaccine.2006.11.049.
54. Castel G, Chtéoui M, Heyd B, Tordo N. Phage display of combinatorial peptide libraries: application to antiviral research. Molecules 2011; 16:3499-518; PMID:21522083; http://dx.doi.org/10.3390/molecules16053499.
55. Ghosh AK, Moreira LA, Jacobs-Lorena M. Plasmodium-mosquito interactions, phage display libraries and transgenic mosquitoes impaired for malaria transmission. Insect Biochem Mol Biol 2002; 32:1325-31; PMID:12225923; http://dx.doi.org/10.1016/S0965-1748(02)00095-4.
56. Ghosh AK, Ribolla PE, Jacobs-Lorena M. Targeting Plasmodium ligands on mosquito salivary glands and midgut with a phage display peptide library. Proc Natl Acad Sci USA 2001; 98:13278-81; PMID:11687659; http://dx.doi.org/10.1073/ pnas.241491198.
57. Gazarian KG, Solis CF, Gazarian TG, Rowley M, Laclette JP. Synthetic peptide-targeted selection of phage display mimotopes highlights immunogenic features of α-helical vs non-helical epitopes of Taenia solium paramyosin: implications for parasite- and host-protective roles of the protein. Peptides 2012; 34:232-41; PMID:22015270; http://dx.doi.org/10.1016/j.peptides.2011.10. 003.
58. Liu Y, Brindley PJ, Zeng Q, Li Y, Zhou J, Chen Y, et al. Identification of phage display peptides with affinity for the tegument of Schistosoma japonicum schistosomula. Mol Biochem Parasitol 2011; 180:86-98; PMID:21930161; http://dx.doi.org/10.1016/j.molbiopara.2011.09.001.
59. Gnanasekar M, Rao KV, He YX, Mishra PK, Nutman TB, Kaliraj P, et al. Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infect Immun 2004; 72:4707-15; PMID:15271932; http://dx.doi.org/10.1128/IAI.72.8.4707-4715.2004.
60. Adda CG, Tilley L, Anders RF, Foley M. Isolation of peptides that mimic epitopes on a malarial antigen from random peptide libraries displayed on phage. Infect Immun 1999; 67:4679-88; PMID:10456916.
61. Yang G, Gao Y, Dong J, Xue Y, Fan M, Shen B, et al. A novel peptide isolated from phage library to substitute a complex system for a vaccine against staphylococci infection. Vaccine 2006; 24:1117-23; PMID:16359760; http://dx.doi.org/10.1016/j.vaccine.2005.09.004.
62. Yang G, Gao Y, Dong J, Liu C, Xue Y, Fan M, et al. A novel peptide screened by phage display can mimic TRAP antigen epitope against Staphylococcus aureus infections. J Biol Chem 2005; 280:27431-5; PMID:15908434; http://dx.doi.org/10.1074/jbc.M501127200.
63. Li Y, Han WY, Li ZJ, Lei LC. Klebsiella pneumoniae MrkD adhesin-mediated immunity to respiratory infection and mapping the antigenic epitope by phage display library. Microb Pathog 2009; 46:144-9; PMID:19100827; http://dx.doi.org/10.1016/j.micpath.2008.11.006.
64. Beghetto E, De Paolis F, Montagnani F, Cellesi C, Gargano N. Discovery of new Mycoplasma pneumoniae antigens by use of a whole-genome lambda display library. Microbes Infect 2009; 11:66-73; PMID:18992837; http://dx.doi.org/10. 1016/j.micinf.2008.10.004.
65. Magliani W, Polonelli L, Conti S, Salati A, Rocca PF, Cusumano V, et al. Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes. Nat Med 1998; 4:705-9; PMID:9623980; http://dx.doi.org/10.1038/nm0698-705.
66. Beckmann C, Brittnacher M, Ernst R, Mayer-Hamblett N, Miller SI, Burns JL. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect Immun 2005; 73:444-52; PMID:15618183; http://dx.doi.org/10.1128/IAI.73.1.444-452.2005.
67. Yang Q, Wang L, Lu DN, Gao RJ, Song JN, Hua PY, et al. Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice. Vaccine 2005; 23:4088-96; PMID:15963364; http://dx.doi.org/10.1016/j.vaccine.2004.07.005.
68. Wang G, Sun M, Fang J, Yang Q, Tong H, Wang L. Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice. Vaccine 2006; 24:6065-73; PMID:16842891; http://dx.doi.org/10.1016/j.vaccine.2006.05. 022.
69. Bliss JM, Sullivan MA, Malone J, Haidaris CG. Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae. J Clin Microbiol 2003; 41:1152-60; PMID:12624045; http://dx.doi.org/10.1128/JCM.41.3.1152-1160.2003.
70. Krishnaswamy S, Kabir ME, Miyamoto M, Furuichi Y, Komiyama T. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution. Anal Biochem 2009; 395:16-24; PMID:19665444; http://dx.doi.org/10.1016/j.ab.2009.08.003.
71. Meijler MM, Matsushita M, Wirsching P, Janda KD. Development of immunopharmacotherapy against drugs of abuse. Curr Drug Discov Technol 2004; 1:77-89; PMID:16472221; http://dx.doi.org/10.2174/1570163043484851.
72. Moreno AY, Mayorov AV, Janda KD. Impact of distinct chemical structures for the development of a methamphetamine vaccine. J Am Chem Soc 2011; 133:6587-95; PMID:21473576; http://dx.doi.org/10.1021/ja108807j.
73. Moreno AY, Azar MR, Warren NA, Dickerson TJ, Koob GF, Janda KD. A critical evaluation of a nicotine vaccine within a self-administration behavioral model. Mol Pharm 2010; 7:431-41; PMID:20104903; http://dx.doi.org/10. 1021/mp900213u.
74. Treweek JB, Janda KD. An antidote for acute cocaine toxicity. Mol Pharm 2012; 9:969-78; PMID:22380623; http://dx.doi.org/10.1021/mp200588v.
75. Carrera MR, Kaufmann GF, Mee JM, Meijler MM, Koob GF, Janda KD. Treating cocaine addiction with viruses. Proc Natl Acad Sci USA 2004; 101:10416-21; PMID:15226496; http://dx.doi.org/10.1073/pnas.0403795101.
76. Meijler MM, Kaufmann GF, Qi L, Mee JM, Coyle AR, Moss JA, et al. Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies. J Am Chem Soc 2005; 127:2477-84; PMID:15725002; http://dx.doi.org/10.1021/ja043935e.
77. Anni H, Nikolaeva O, Israel Y. Selection of phage-display library peptides recognizing ethanol targets on proteins. Alcohol 2001; 25:201-9; PMID:11839467; http://dx.doi.org/10.1016/S0741-8329(01)00164-1.
78. Dickerson TJ, Janda KD. Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy. AAPS J 2005; 7:E579-86; PMID:16353936; http://dx.doi.org/10.1208/aapsj070359.
79. Naz RK. Antisperm vaccine for contraception. Am J Reprod Immunol 2005; 54:378-83; PMID:16305663; http://dx.doi.org/10.1111/j.1600-0897.2005.00331.x.
80. Naz RK, Zhu X. Recombinant fertilization antigen-1 causes a contraceptive effect in actively immunized mice. Biol Reprod 1998; 59:1095-100; PMID:9780314; http://dx.doi.org/10.1095/biolreprod59.5.1095.
81. Naz RK, Chauhan SC. Human sperm-specific peptide vaccine that causes long-term reversible contraception. Biol Reprod 2002; 67:674-80; PMID:12135913; http://dx.doi.org/10.1095/biolreprod67.2.674.
82. O'Rand MG, Beavers J, Widgren EE, Tung KS. Inhibition of fertility in female mice by immunization with a B-cell epitope, the synthetic sperm peptide, P10G. J Reprod Immunol 1993; 25:89-102; PMID:7513024; http://dx.doi.org/10.1016/ 0165-0378(93)90051-I.
83. Lea IA, van Lierop MJ, Widgren EE, Grootenhuis A, Wen Y, van Duin M, et al. A chimeric sperm peptide induces antibodies and strain-specific reversible infertility in mice. Biol Reprod 1998; 59:527-36; PMID:9716550; http://dx.doi.org/10.1095/biolreprod59.3.527.
84. Hardy CM, Mobbs KJ. Expression of recombinant mouse sperm protein sp56 and assessment of its potential for use as an antigen in an immunocontraceptive vaccine. Mol Reprod Dev 1999; 52:216-24; PMID:9890753; http://dx.doi.org/10. 1002/(SICI)1098-2795(199902)52:2〈216::AIDMRD13〉 3.0.CO;2-R.
85. Naz RK. Development of genetically engineered human sperm immunocontraceptives. J Reprod Immunol 2009; 83:145-50; PMID:19853924; http://dx.doi.org/10.1016/j.jri.2009.06.260.
86. O'rand MG, Widgren EE, Sivashanmugam P, Richardson RT, Hall SH, French FS, et al. Reversible immunocontraception in male monkeys immunized with eppin. Science 2004; 306:1189-90; PMID:15539605; http://dx.doi.org/10.1126/science. 1099743.
87. Samoylova TI, Cox NR, Cochran AM, Samoylov AM, Griffin B, Baker HJ. ZP-binding peptides identified via phage display stimulate production of sperm antibodies in dogs. Anim Reprod Sci 2010; 120:151-7; PMID:20434854; http://dx.doi.org/10.1016/j.anireprosci.2010.04.002.
88. Naz RK. Antisperm contraceptive vaccines: where we are and where we are going? Am J Reprod Immunol 2011; 66:5-12; PMID:21481057; http://dx.doi.org/10. 1111/j.1600-0897.2011.01000.x.
89. Davies JM, O'hehir RE, Suphioglu C. Use of phage display technology to investigate allergen-antibody interactions. J Allergy Clin Immunol 2000; 105:1085-92; PMID:10856140; http://dx.doi.org/10.1067/mai.2000.107040.
90. Steinberger P, Kraft D, Valenta R. Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. J Biol Chem 1996; 271:10967-72; PMID:8631916.
91. Droupadi PR, Varga JM, Linthicum DS. Mechanism of allergenic cross-reactions--IV. Evidence for participation of aromatic residues in the ligand binding site of two multi-specific IgE monoclonal antibodies. Mol Immunol 1994; 31:537-48; PMID:8190129; http://dx.doi.org/10.1016/0161-5890(94)90041-8.
92. Flicker S, Vrtala S, Steinberger P, Vangelista L, Bufe A, Petersen A, et al. A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain. J Immunol 2000; 165:3849-59; PMID:11034391.
93. Hantusch B, Knittelfelder R, Wallmann J, Krieger S, Szalai K, Untersmayr E, et al. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a. Mol Immunol 2006; 43:2180-7; PMID:16510185; http://dx.doi.org/10.1016/j.molimm.2006.01.009.
94. de Lalla C, Tamborini E, Longhi R, Tresoldi E, Manoni M, Siccardi AG, et al. Human recombinant antibody fragments specific for a rye-grass pollen allergen: characterization and potential applications. Mol Immunol 1996; 33:1049-58; PMID:9010244; http://dx.doi.org/10.1016/S0161-5890(96)00061-2.
95. Jensen-jarolim E, Leitner A, Kalchhauser H, Zürcher A, Ganglberger E, Bohle B, et al. Peptide mimotopes displayed by phage inhibit antibody binding to bet v 1, the major birch pollen allergen, and induce specific IgG response in mice. FASEB J 1998; 12:1635-42; PMID:9837853.
96. Tawde P, Venkatesh YP, Wang F, Teuber SS, Sathe SK, Roux KH. Cloning and characterization of profilin (Pru du 4), a cross-reactive almond (Prunus dulcis) allergen. J Allergy Clin Immunol 2006; 118:915-22; PMID:17030246; http://dx.doi.org/10.1016/j.jaci.2006.05.028.
97. Leung PS, Chen YC, Gershwin ME, Wong SH, Kwan HS, Chu KH. Identification and molecular characterization of Charybdis feriatus tropomyosin, the major crab allergen. J Allergy Clin Immunol 1998; 102:847-52; PMID:9819304; http://dx.doi.org/10.1016/S0091-6749(98)70027-2.
98. Furmonaviciene R, Tighe PJ, Clark MR, Sewell HF, Shakib F. The use of phage-peptide libraries to define the epitope specificity of a mouse monoclonal anti-Der p 1 antibody representative of a major component of the human immunoglobulin E anti-Der p 1 response. Clin Exp Allergy 1999; 29:1563-71; PMID:10520087; http://dx.doi.org/10.1046/j.1365-2222.1999.00686.x.
99. Kodzius R, Rhyner C, Konthur Z, Buczek D, Lehrach H, Walter G, et al. Rapid identification of allergen-encoding cDNA clones by phage display and high-density arrays. Comb Chem High Throughput Screen 2003; 6:147-54; PMID:12678710; http://dx.doi.org/10.2174/1386207033329751.
100. Bittner C, Grassau B, Frenzel K, Baur X. Identification of wheat gliadins as an allergen family related to baker's asthma. J Allergy Clin Immunol 2008; 121:744-9; PMID:18036646; http://dx.doi.org/10.1016/j.jaci.2007.09.051.
101. Burks AW, Williams LW, Helm RM, Connaughton C, Cockrell G, O'Brien T. Identification of a major peanut allergen, Ara h I, in patients with atopic dermatitis and positive peanut challenges. J Allergy Clin Immunol 1991; 88:172-9; PMID:1880317; http://dx.doi.org/10.1016/0091-6749(91)90325-I.
102. Burks AW, Williams LW, Connaughton C, Cockrell G, O'Brien TJ, Helm RM. Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge. J Allergy Clin Immunol 1992; 90:962-9; PMID:1460200; http://dx.doi.org/10.1016/0091-6749(92)90469-I.
103. Naseem S, Meens J, Jores J, Heller M, Dübel S, Hust M, et al. Phage display-based identification and potential diagnostic application of novel antigens from Mycoplasma mycoides subsp. mycoides small colony type. Vet Microbiol 2010; 142:285-92; PMID:19900769; http://dx.doi.org/10.1016/j.vetmic. 2009.09.071.
104. Meyer T, Schirrmann T, Frenzel A, Miethe S, Stratmann-Selke J, Gerlach GF, et al. Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display. BMC Biotechnol 2012; 12:29; PMID:22703709; http://dx.doi.org/10.1186/1472-6750-12-29.
105. Chen Y, Liu B, Yang D, Li X, Wen L, Zhu P, et al. Peptide mimics of peptidoglycan are vaccine candidates and protect mice from infection with Staphylococcus aureus. J Med Microbiol 2011; 60:995-1002; PMID:21436375; http://dx.doi.org/10.1099/jmm.0.028647-0.
106. Buczkowski H, Parida S, Bailey D, Barrett T, Banyard AC. A novel approach to generating morbillivirus vaccines: negatively marking the rinderpest vaccine. Vaccine 2012; 30:1927-35; PMID:22265946; http://dx.doi.org/10.1016/j. vaccine.2012.01.029.
107. Charles-Niño C, Pedroza-Roldan C, Viveros M, Gevorkian G, Manoutcharian K. Variable epitope libraries: new vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response. Vaccine 2011; 29:5313-21; PMID:21600948; http://dx.doi.org/10.1016/j. vaccine.2011.05.007.
108. Zhou M, Kostoula I, Brill B, Panou E, Sakarellos-Daitsiotis M, Dietrich U. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice. Vaccine 2012; 30:1911-6; PMID:22269872; http://dx.doi.org/10.1016/j.vaccine.2012.01.026.